Tower Research Capital LLC (TRC) - ENZON PHARMACEUTICALS INC ownership

ENZON PHARMACEUTICALS INC's ticker is ENZN and the CUSIP is 293904108. A total of 52 filers reported holding ENZON PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ENZON PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2015$1,0002,177
+2077.0%
0.00%
Q2 2015$0
-100.0%
100
-98.9%
0.00%
-100.0%
Q1 2015$10,000
-56.5%
9,519
-55.8%
0.00%
-50.0%
Q4 2014$23,000
-37.8%
21,536
-36.9%
0.00%
-50.0%
Q3 2014$37,000
+48.0%
34,148
+40.4%
0.00%
+33.3%
Q2 2014$25,000
+47.1%
24,314
+44.3%
0.00%
+50.0%
Q1 2014$17,00016,8460.00%
Other shareholders
ENZON PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Baupost Group 4,337,858$5,032,0000.14%
PRICE MICHAEL F 748,200$868,0000.11%
ALGERT GLOBAL LLC 124,891$145,0000.04%
Rotella Capital Management, Inc. 13,701$16,0000.03%
Icahn Capital 5,904,863$6,850,0000.02%
Spark Investment Management LLC 110,100$127,0000.02%
FCG ADVISORS, LLC 20,000$23,0000.02%
BRANDES INVESTMENT PARTNERS, LP 1,023,893$1,188,0000.02%
GLOBEFLEX CAPITAL L P 101,454$117,0000.01%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 129,089$149,0000.01%
View complete list of ENZON PHARMACEUTICALS INC shareholders